PLAT and stroke disorder: In contrast, the combination of tPA plus 3K3A-APC as compared with control significantly reduced infarct volume at 24 h (65% reduction) and at 7 days (63% reduction) following MCAO in mice and at 7 days (52% reduction) after embolic stroke in rats (p < 0.05).